Top Markets
#1 Islamic Coin Islamic Coin +152.28%
#2 Bitway Bitway +55.04%
#3 Starpower Starpower +45.07%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.47%
#5 aelf aelf +24.96%
#6 SkyAI SkyAI +16.85%
#7 Pons Pons +15.81%
#8 DAPPOS DAPPOS +14.72%
#9 龙虾 (Lobster) 龙虾 (Lobster) +14.18%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Classement en actions #29654
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Prix de l'action
$0.68377137
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$20.23M
Changement (1 jour)
-0.60%
Changement (1 an)
0.00%
Pays
SE
Échange Medivir AB (publ) (MVIR-B)

Catégorie

Healthcare
Historique du rendement du dividende pour Medivir AB (publ) (MVIR-B)
Le rendement du dividende (TTM) de Medivir AB (publ) (symbole boursier : MVIR-B) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Medivir AB (publ) (MVIR-B) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR